Skip to main content

Table 3 Analysis of COPD and smoking interactions on HSA and carbonylated HSA

From: Oxidative modification of albumin in the parenchymal lung tissue of current smokers with chronic obstructive pulmonary disease

HSA

Term

Î’

SE

P value

COPD

-0.6090

0.0029

0.001

Smoking status

-0.0651

0.0580

0.037

COPD × smoking

-0.3716

0.0170

<0.001

Carbonylated HSA molecules/HSA molecule

Term

Î’

SE

P value

COPD

-0.579

0.0053

0.001

Smoking status

-0.861

0.0035

0.001

COPD × smoking

-0.553

0.0033

0.007

  1. Values are means ± plusorminus SD for non-continuous data unless otherwise stated
  2. HSA, human serum albumin; COPD, ratio of air forcibly exhaled in one second (FEV1) to the forced vital capacity (FVC) pre-bronchodilator use (FEV1/FVC < 70%) and FEV1 ≤ 80% predicted; Smoking, current smoking history.